Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg
Clinical trial NCT02955472 · COMPLETED
Trial details
- NCT number
- NCT02955472
- Sponsor
- GL Pharm Tech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.